Inhaled β2-agonists in asthma management: an evolving story

Inhaled β2-agonists in asthma management: an evolving story

Bibliographic Details
Main Authors:	Diana Silva, Tiago Jacinto
Format:	Article
Language:	English
Published:	European Respiratory Society 2016-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/12/4/375.full

Similar Items

Cough and asthma: the role of inhaled corticosteroids and ß2-agonists
by: Mario Cazzola, et al.
Published: (2008-02-01)

Effects of the Addition of Beta2-agonist Tulobuterol Patches to Inhaled Corticosteroid in Patients with Asthma
by: Soichiro Hozawa, et al.
Published: (2009-01-01)

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01)

Markers of asthma control and resource utilization with steroid and long-acting beta 2 agonists in a single inhaler in asthma ??
by: Chi-Hua Chen, et al.
Published: (2007)

The Effects of Inhaled β-Adrenergic Agonists in Transient Tachypnea of the Newborn
by: Esengul Keleş MD, et al.
Published: (2016-05-01)

The effect of adding long acting beta 2 agonists to inhaled corticosteroids versus increasing dose of inhaled corticosteroids in improving asthma control
by: Nisreen M. Nabil, et al.
Published: (2014-10-01)

Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β-adrenoceptor agonist, with formoterol in patients with asthma
by: Leif Bjermer, et al.
Published: (2013-10-01)

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
by: Ian D. Pavord, et al.
Published: (2017-03-01)

The Relationship among the Inspiratory Muscle Strength, the Perception of Dyspnea and Inhaled Beta2-Agonists in Patients with Asthma
by: Paltiel Weiner, et al.
Published: (2002-01-01)

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01)

Review: Safety of long-acting β2 -agonists in the treatment of asthma
by: Mario Cazzola, et al.
Published: (2007-10-01)

Long-acting β2-adrenergic receptor agonist in pediatric asthma
by: Shigemi Yoshihara, et al.
Published: (2004-01-01)

Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn
by: Ahmed A. Talaat, et al.
Published: (2020-01-01)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
by: Lee SY, et al.
Published: (2016-11-01)

Effect of Inhaled β2-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease.
by: Mostafa Amer, et al.
Published: (2016-01-01)

Wheezing Characteristics and Predicting Reactivity to Inhaled β2-Agonist in Children for Home Medical Care
by: Chizu Habukawa, et al.
Published: (2021-10-01)

Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis
by: Gang Wang, et al.
Published: (2017-12-01)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis
by: Van Iterson, E. H., et al.
Published: (2015)

Drug Utilization Evaluation of Inhaled Corticosteroid and Long-Acting Beta2 Adrenergic Agonist Combination Therapy in Asthma Children
by: Ya-ChuanChang, et al.
Published: (2011)

Pharmacokinetic and pharmacodynamic characterization of inhaled β2 - agonists using the isolated human lung perfusion model
by: Gnadt, Mirjam
Published: (2010)

Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics
by: Marco Caminati, et al.
Published: (2020-04-01)

Inhalation of β2 agonists impairs the clearance of nontypable <it>Haemophilus influenzae </it>from the murine respiratory tract
by: de Vos Alex F, et al.
Published: (2006-04-01)

β2-Adrenoreceptor Agonist Inhalation During Ex Vivo Lung Perfusion Attenuates Lung Injury
by: Kondo, Takeshi
Published: (2016)

Pharmacogenetics of inhaled beta-2-agonists and athletic performance
by: Koch, Sarah
Published: (2011)

Pharmacogenetics of inhaled beta-2-agonists and athletic performance
by: Koch, Sarah
Published: (2011)

Pharmacogenetics of inhaled beta-2-agonists and athletic performance
by: Koch, Sarah
Published: (2011)

Reduced suppressive effect of β2-adrenoceptor agonist on fibrocyte function in severe asthma
by: Chun-Yu Lo, et al.
Published: (2017-11-01)

The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
by: Cheng-Yi Wang, et al.
Published: (2021-04-01)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
by: Scichilone N, et al.
Published: (2014-11-01)

Impulse Oscillometry; Therapeutic Impacts of Transdermal Long-Acting Beta-2 Agonist Patch in Elderly Asthma with Inhaled Corticosteroid Alone
by: Hiroshi Tanaka, et al.
Published: (2012-01-01)

Assessing asthma in adult clinical trials of inhaled B2-agonists : a search for a standard primary outcome measure
by: Dennis, Sarah M.
Published: (2002)

Beta2-Agonists and Asthma in Children
by: Guy Lapierre
Published: (1995-01-01)

Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects.
by: Mais Ali-Saleh, et al.
Published: (2016-01-01)

Indacaterol: A novel, Inhaled Beta-2 agonist for COPD
by: Ved Prakash, et al.
Published: (2015-01-01)

MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01)

MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
by: Yu.G. Levina, et al.
Published: (2008-05-01)

Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered a pressurized metered-dose inhaler
by: Cedric Van Holsbeke, et al.
Published: (2018-02-01)

Asthma management with breath-triggered inhalers: innovation through design
by: Mário Morais-Almeida, et al.
Published: (2020-06-01)

Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years
by: Michael J. McGeachie, et al.
Published: (2020-03-01)